Clinical Trials Sponsored by Alsius Corporation

Total 10270 results

Topcon Corporation

Completed

TRK-3 Performance of Pachymetry

Normal

United States
Masimo Corporation

Completed

Clinical Performance of Masimo INVSENSOR00040

Healthy

United States
Incyte Corporation

Active, not recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Cervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditions

Finland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
Insulet Corporation

Completed

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

Type 1 Diabetes Mellitus

United States
Kerr Corporation

Terminated

Clinical Evaluation of OBU When Used for Indirect Dental Restorations

Sensitivity, Tooth

United States
Incyte Corporation

Active, not recruiting

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Lymphoma

Belgium, United States, France, Israel, Italy, United Kingdom, Germany, Spain, Poland, Australia, Argentina, Denmark
Spectranetics Corporation

Completed

ILLUMENATE Pivotal Post-Approval Study (PAS)

Peripheral Artery Disease

United States, Austria
Glaukos Corporation

Completed

Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

Progressive Keratoconus

United States
Spectranetics Corporation

Completed

ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)

Peripheral Arterial Disease

Netherlands, Germany, United Kingdom
Incyte Corporation

Active, not recruiting

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)

Lymphoma

United States, Spain, Italy, Israel, Poland, United Kingdom, Canada, Czechia, Germany, Denmark, Australia, Hungary, Sweden
PhytoHealth Corporation

Completed

Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers

Healthy

Taiwan
PhytoHealth Corporation

Completed

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Hemorrhagic Stroke

Taiwan
PhytoHealth Corporation

Completed

Study of PHN131 in Patients After Surgery

Analgesia Disorder

Taiwan
PhytoHealth Corporation

Completed

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Taiwan
PhytoHealth Corporation

Withdrawn

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

Cancer | Fatigue | Surgery

Taiwan
Incyte Corporation

Active, not recruiting

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor ((CITADEL-205))

Lymphoma

United States, Spain, France, United Kingdom, Czechia, Israel, Belgium, Italy, Germany, Poland, Denmark
Pulmonx Corporation

Active, not recruiting

Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion (COVE)

Pulmonary Emphysema

Australia
Candela Corporation

Completed

Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin

Aged Skin
Incyte Corporation

Completed

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa | Acne Inversa

United States, Canada, France, Germany, Poland, Spain
Incyte Corporation

Completed

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, France, Canada, Hungary, Poland, Germany, Italy
Incyte Corporation

Completed

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Germany, Spain, Canada, Poland, Czechia, Bulgaria
Glaukos Corporation

Active, not recruiting

Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

Ocular Hypertension | Glaucoma, Open-Angle

United States
Glaukos Corporation

Completed

Study of Exchange of Travoprost Intraocular Implant

Open Angle Glaucoma

United States, Philippines
Erchonia Corporation

Completed

An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring

Circumference Reduction

United States
Erchonia Corporation

Completed

An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2

Autistic Disorder

United States
Erchonia Corporation

Withdrawn

A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus

Onychomycosis of Toenail

United States
Erchonia Corporation

Completed

The Effect of the Erchonia GVL Low Level Laser Therapy on Neck and Shoulder Pain

Musculoskeletal Pain

United States
Candela Corporation

Completed

Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions

Pigmented Lesions | Skin Texture

United States
Axogen Corporation

Completed

Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON)

Peripheral Nerve Discontinuities

United States
Topcon Corporation

Completed

OCT Angiography Software Evaluation Study

Retina Condition Followed by Fluorescein Angiography Imaging

United States
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Insulet Corporation

Completed

Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Incyte Corporation

Completed

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Lymphoma

United States
Antengene Corporation

Active, not recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (SEARCH)

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

China
Incyte Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

UC (Urothelial Cancer)

United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
Incyte Corporation

Terminated

Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

Solid Tumor Malignancy

United States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
Antengene Corporation

Terminated

A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (MATCH)

Relapsed/Refractory Diffuse Large B-cell Lymphoma

China
Allievex Corporation

Active, not recruiting

A Treatment Extension Study of Mucopolysaccharidosis Type IIIB

Mucopolysaccharidosis Type IIIB | MPS III B

Germany, United States, Turkey, United Kingdom, Colombia, Spain, Taiwan
Masimo Corporation

Terminated

Effect of Skin Pigmentation and Race/Ethnicity Factors on the Accuracy of Masimo Pulse Oximeters

Healthy

United States
Incyte Corporation

Completed

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Vitiligo

United States
Incyte Corporation

Completed

A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Squamous Cell Carcinoma of Anal Canal

Spain, United Kingdom, United States, Germany, Belgium, France, Denmark, Italy, Norway
Cerus Corporation

Completed

In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days

Healthy

United States
Symvivo Corporation

Completed

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

COVID-19

Australia
Yuhan Corporation

Completed

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (CORONA)

Hypertension | Dyslipidemias

Korea, Republic of
Masimo Corporation

Completed

Desaturation Validation of INVSENSOR00039

Healthy

United States
Incyte Corporation

No longer available

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Aplastic Anemia
Incyte Corporation

Completed

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Glaukos Corporation

Terminated

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (GCF-041)

Glaucoma, Open-Angle

Germany
Glaukos Corporation

Terminated

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Primary Open Angle Glaucoma (POAG)

Brazil
Glaukos Corporation

Completed

Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication

Open Angle Glaucoma

Armenia

Clinical Trials Sponsored by Alsius Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations